IBI322 Monotherapy or Combination Therapy in Subjects With Advanced Malignant Tumors.

Clinical trial NCT04912466 · COMPLETED

Trial details

NCT number: NCT04912466
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2021-07-21
Primary completion: 2022-12-03
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.